Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Impact of a telephone-first consultation system in general practice.

Miller D, Loftus AM, O'Boyle PJ, McCloskey M, O'Kelly J, Mace D, McKeon N, Ewan SL, Moore L, Abbott A, Cunning S, McCarron MO, Paget AM.

Postgrad Med J. 2019 Jul 20. pii: postgradmedj-2019-136557. doi: 10.1136/postgradmedj-2019-136557. [Epub ahead of print]

PMID:
31326942
2.

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.

Saunders EJ, Dadaev T, Leongamornlert DA, Al Olama AA, Benlloch S, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pasayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Pandha H, Govindasami K, Muir K; UK Genetic Prostate Cancer Study Collaborators; UK ProtecT Study Collaborators; PRACTICAL Consortium, Easton DF, Eeles RA, Kote-Jarai Z.

Br J Cancer. 2016 Apr 12;114(8):945-52. Erratum in: Br J Cancer. 2018 Feb 13;:.

3.

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans.

Amin Al Olama A, Dadaev T, Hazelett DJ, Li Q, Leongamornlert D, Saunders EJ, Stephens S, Cieza-Borrella C, Whitmore I, Benlloch Garcia S, Giles GG, Southey MC, Fitzgerald L, Gronberg H, Wiklund F, Aly M, Henderson BE, Schumacher F, Haiman CA, Schleutker J, Wahlfors T, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, Mcdonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokołorczyk D, Kluzniak W, Cannon-Albright L, Brenner H, Butterbach K, Arndt V, Park JY, Sellers T, Lin HY, Slavov C, Kaneva R, Mitev V, Batra J, Clements JA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Govindasami K, Guy M, Lophatonanon A, Muir K, Viñuela A, Brown AA; PRACTICAL Consortium; COGS-CRUK GWAS-ELLIPSE (Part of GAME-ON) Initiative; Australian Prostate Cancer BioResource; UK Genetic Prostate Cancer Study Collaborators; UK ProtecT Study Collaborators, Freedman M, Conti DV, Easton D, Coetzee GA, Eeles RA, Kote-Jarai Z.

Hum Mol Genet. 2015 Oct 1;24(19):5589-602. doi: 10.1093/hmg/ddv203. Epub 2015 May 29.

4.

De novo HLA sensitization and antibody mediated rejection following pregnancy in a heart transplant recipient.

O'Boyle PJ, Smith JD, Danskine AJ, Lyster HS, Burke MM, Banner NR.

Am J Transplant. 2010 Jan;10(1):180-3. doi: 10.1111/j.1600-6143.2009.02875.x. Epub 2009 Nov 24.

5.

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.

Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, Schleutker J, Hamdy FC, Neal DE, Donovan JL, Stanford JL, Ostrander EA, Ingles SA, John EM, Thibodeau SN, Schaid D, Park JY, Spurdle A, Clements J, Dickinson JL, Maier C, Vogel W, Dörk T, Rebbeck TR, Cooney KA, Cannon-Albright L, Chappuis PO, Hutter P, Zeegers M, Kaneva R, Zhang HW, Lu YJ, Foulkes WD, English DR, Leongamornlert DA, Tymrakiewicz M, Morrison J, Ardern-Jones AT, Hall AL, O'Brien LT, Wilkinson RA, Saunders EJ, Page EC, Sawyer EJ, Edwards SM, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper CS, Southey MC, Lophatananon A, Liu JF, Kolonel LN, Le Marchand L, Wahlfors T, Tammela TL, Auvinen A, Lewis SJ, Cox A, FitzGerald LM, Koopmeiners JS, Karyadi DM, Kwon EM, Stern MC, Corral R, Joshi AD, Shahabi A, McDonnell SK, Sellers TA, Pow-Sang J, Chambers S, Aitken J, Gardiner RA, Batra J, Kedda MA, Lose F, Polanowski A, Patterson B, Serth J, Meyer A, Luedeke M, Stefflova K, Ray AM, Lange EM, Farnham J, Khan H, Slavov C, Mitkova A, Cao G; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators; PRACTICAL Consortium, Easton DF.

Nat Genet. 2009 Oct;41(10):1116-21. doi: 10.1038/ng.450. Epub 2009 Sep 20.

6.

Multiple loci on 8q24 associated with prostate cancer susceptibility.

Al Olama AA, Kote-Jarai Z, Giles GG, Guy M, Morrison J, Severi G, Leongamornlert DA, Tymrakiewicz M, Jhavar S, Saunders E, Hopper JL, Southey MC, Muir KR, English DR, Dearnaley DP, Ardern-Jones AT, Hall AL, O'Brien LT, Wilkinson RA, Sawyer E, Lophatananon A; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK Prostate testing for cancer and Treatment study (ProtecT Study) Collaborators, Horwich A, Huddart RA, Khoo VS, Parker CC, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper C, Donovan JL, Hamdy FC, Neal DE, Eeles RA, Easton DF.

Nat Genet. 2009 Oct;41(10):1058-60. doi: 10.1038/ng.452. Epub 2009 Sep 20.

PMID:
19767752
7.

High-power KTP laser for the treatment of symptomatic benign prostatic enlargement.

Carter A, Sells H, O'Boyle PJ.

BJU Int. 1999 May;83(7):857-8. No abstract available.

PMID:
10368213
8.

An MRSA outbreak in a urology ward and its association with Nd:YAG coagulation laser treatment of the prostate.

Jones JW, Carter A, Ewings P, O'Boyle PJ.

J Hosp Infect. 1999 Jan;41(1):39-44.

PMID:
9949963
9.

MRSA and minimally invasive treatments for benign prostatic hypertrophy.

Jones JW, O'Boyle PJ.

Lancet. 1998 Jun 20;351(9119):1888. No abstract available.

PMID:
9652696
10.

The use of generic measures of health-related quality of life in the assessment of outcome from transurethral resection of the prostate.

MacDonagh RP, Cliff AM, Speakman MJ, O'Boyle PJ, Ewings P, Gudex C.

Br J Urol. 1997 Mar;79(3):401-8.

PMID:
9117222
11.

Multiple use of fibres in the visual laser ablation of the prostate.

Gilbert HW, O'Boyle PJ, McLoughlin J, Speakman MJ.

Br J Urol. 1996 Jun;77(6):839-42.

PMID:
8705218
13.

Using the 'pusher first' technique to facilitate insertion of J-J stent guidewire.

McLoughlin J, O'Boyle PJ.

Br J Urol. 1996 Jan;77(1):151. No abstract available.

PMID:
8653290
14.

Periurethral Teflon for stress urinary incontinence: medium-term results.

Harrison SC, Brown C, O'Boyle PJ.

Br J Urol. 1993 Jan;71(1):25-7.

PMID:
8435732
15.

Video-endoscopy: the remote operating technique.

O'Boyle PJ.

Br J Urol. 1990 Jun;65(6):557-9. Review. No abstract available.

PMID:
2196968
16.

Videoprostatectomy. Guidelines for choosing an effective microvideo operating system.

O'Boyle PJ, Raina S, Holdoway AT.

Br J Urol. 1989 Jun;63(6):624-6.

PMID:
2752256
17.
18.

Ultrasound scanning by the urologist in outpatient clinics.

Vesey SG, O'Boyle PJ, Lumb GN.

Br J Surg. 1988 Sep;75(9):921-2. No abstract available.

PMID:
3052695
19.

Teflon injection in female stress incontinence. Effect on urethral pressure profile and flow rate.

Vesey SG, Rivett A, O'Boyle PJ.

Br J Urol. 1988 Jul;62(1):39-41.

PMID:
3408866
20.

An evaluation of urologist-operated ultrasound and its use in the urological out-patient clinic.

Vesey SG, Lumb GN, O'Boyle PJ.

Br J Urol. 1988 Jan;61(1):74-6.

PMID:
3277689

Supplemental Content

Loading ...
Support Center